{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:47:59Z","timestamp":1740109679145,"version":"3.37.3"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R03HD079870-01A1"],"award-info":[{"award-number":["1R03HD079870-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ejphar.2024.176567","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T08:28:51Z","timestamp":1712219331000},"page":"176567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Continuous oral olanzapine or clozapine treatment initiated in adolescence has differential short- and long-term impacts on antipsychotic sensitivity than those initiated in adulthood"],"prefix":"10.1016","volume":"972","author":[{"given":"Ruiyong","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnyi","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176567_bib1","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/cercor\/10.10.1014","article-title":"Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: implications for the development of psychopathology","volume":"10","author":"Benes","year":"2000","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ejphar.2024.176567_bib2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.expneurol.2016.06.012","article-title":"Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia","volume":"283","author":"Bikovsky","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176567_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1071976","article-title":"A comprehensive approach to modeling maternal immune activation in rodents","volume":"16","author":"Bucknor","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176567_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113145","article-title":"Maternal immune activation and repeated maternal separation alter offspring conditioned avoidance response learning and antipsychotic response in male rats","volume":"403","author":"Chou","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.brainres.2015.05.036","article-title":"Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia","volume":"1618","author":"Chou","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib6","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/NDT.S158545","article-title":"Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors","volume":"14","author":"De Santis","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.ejphar.2024.176567_bib7","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.3390\/ijms17111944","article-title":"Early antipsychotic treatment in juvenile rats elicits long-term alterations to the dopamine neurotransmitter system","volume":"17","author":"De Santis","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176567_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbr.2017.04.013","article-title":"Time-dependent sensitization of antipsychotic effect in adolescent male and female rats","volume":"328","author":"Ding","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.mp.4000520","article-title":"Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice","volume":"4","author":"Fatemi","year":"1999","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib10","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00213-014-3756-2","article-title":"Effects of central activation of serotonin 5-HT2A\/2C or dopamine D2\/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test","volume":"232","author":"Feng","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2024.176567_bib11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pbb.2012.09.013","article-title":"Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis","volume":"103","author":"Feng","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2024.176567_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbr.2012.10.009","article-title":"Environmental and behavioral controls of the expression of clozapine tolerance: evidence from a novel across-model transfer paradigm","volume":"238","author":"Feng","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pbb.2017.04.001","article-title":"Sex differences in aripiprazole sensitization from adolescence to adulthood","volume":"156","author":"Freeman","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2024.176567_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbr.2013.09.050","article-title":"Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism","volume":"257","author":"Gao","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pnpbp.2014.05.015","article-title":"Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood","volume":"54","author":"Gao","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/0269881114565937","article-title":"Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function","volume":"29","author":"Gao","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.euroneuro.2003.10.006","article-title":"Effects of subchronic clozapine treatment on long-term potentiation in rat prefrontal cortex","volume":"14","author":"Gemperle","year":"2004","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.ejphar.2024.176567_bib18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neubiorev.2020.04.012","article-title":"Maternal immune activation by Poly I:C as a preclinical model for neurodevelopmental disorders: a focus on autism and schizophrenia","volume":"113","author":"Haddad","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2024.176567_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nurx.2005.12.003","article-title":"How antipsychotics work-from receptors to reality","volume":"3","author":"Kapur","year":"2006","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejphar.2024.176567_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2024.176567_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0269881116654697","article-title":"Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms","volume":"30","author":"Li","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.npp.1301110","article-title":"Time course of the antipsychotic effect and the underlying behavioral mechanisms","volume":"32","author":"Li","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2024.176567_bib23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pbb.2011.03.007","article-title":"Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment","volume":"98","author":"Li","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2024.176567_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pbb.2011.05.001","article-title":"Time course of prepulse inhibition disruption induced by dopamine agonists and NMDA antagonists: effects of drug administration regimen","volume":"99","author":"Li","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2024.176567_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FBP.0b013e32832a8f66","article-title":"An investigation of the behavioral mechanisms of antipsychotic action using a drug-drug conditioning paradigm","volume":"20","author":"Li","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00702-011-0722-6","article-title":"Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A\/2C receptors","volume":"119","author":"Li","year":"2012","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2024.176567_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-010-1925-5","article-title":"Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning","volume":"212","author":"Li","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2024.176567_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173453","article-title":"The long-lasting effects of early antipsychotic exposure during juvenile period on adult behaviours - a study in a poly I:C rat model","volume":"219","author":"Lian","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2024.176567_bib29","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.pharep.2016.06.003","article-title":"Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats","volume":"68","author":"Lian","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2024.176567_bib30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2024.176567_bib31","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1177\/0269881109102546","article-title":"Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: an interoceptive drug state mechanism","volume":"24","author":"Mead","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbi.2016.07.144","article-title":"Effects of immune activation during early or late gestation on schizophrenia-related behaviour in adult rat offspring","volume":"63","author":"Meehan","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2024.176567_bib33","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.pnpbp.2003.09.010","article-title":"Serotonin receptors: their key role in drugs to treat schizophrenia","volume":"27","author":"Meltzer","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib34","first-page":"390","article-title":"The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs","volume":"25","author":"Meltzer","year":"1989","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ejphar.2024.176567_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057308","article-title":"Olanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function","volume":"8","author":"Milstein","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176567_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.04.035","article-title":"Risperidone induces long-lasting changes in the conditioned avoidance response and accumbal gene expression selectively in animals treated as adolescents","volume":"108","author":"Moe","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176567_bib38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0269881116654776","article-title":"Neural changes induced by antipsychotic administration in adolescence: a review of studies in laboratory rodents","volume":"30","author":"Moe","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2017.04.013","article-title":"Short- and long-term effects of risperidone on catalepsy sensitisation and acquisition of conditioned avoidance response: adolescent vs adult rats","volume":"121","author":"Moe","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","article-title":"Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia","volume":"59","author":"Ozawa","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib41","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1177\/0269881118788822","article-title":"Chronic antipsychotic treatment differentially modulates protein kinase A- and glycogen synthase kinase 3 beta-dependent signaling pathways, N-methyl-D-aspartate receptor and gamma-aminobutyric acid A receptors in nucleus accumbens of juvenile rats","volume":"32","author":"Pan","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaac.2016.03.012","article-title":"Antipsychotic use trends in youth with autism spectrum disorder and\/or intellectual disability: a meta-analysis","volume":"55","author":"Park","year":"2016","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00702-007-0004-5","article-title":"Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays","volume":"115","author":"Perez-Costas","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2024.176567_bib44","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biopsych.2009.07.005","article-title":"Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia","volume":"66","author":"Piontkewitz","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbi.2011.11.004","article-title":"Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats","volume":"26","author":"Piontkewitz","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2024.176567_bib46","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1176\/ajp.155.6.768","article-title":"Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo","volume":"155","author":"Pohjalainen","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib47","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00213-013-3386-0","article-title":"Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?","volume":"231","author":"Qiao","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2024.176567_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/npp.2012.213","article-title":"Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model","volume":"38","author":"Qiao","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2024.176567_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pnpbp.2013.10.005","article-title":"Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood","volume":"48","author":"Qiao","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neuropharm.2013.05.031","article-title":"Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity","volume":"75","author":"Qin","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176567_bib51","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/schbul\/sbq083","article-title":"Antipsychotic dosing: how much but also how often?","volume":"36","author":"Remington","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ejphar.2024.176567_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2011.03.003","article-title":"Role of the dopamine transporter in mediating the neuroleptic-induced reduction of tyrosine hydroxylase-immunoreactive midbrain neurons","volume":"1394","author":"Reynolds","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biopsych.2008.01.010","article-title":"Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery","volume":"64","author":"Samaha","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib54","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","article-title":"\"Breakthrough\" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time","volume":"27","author":"Samaha","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176567_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1023\/A:1022325116309","article-title":"Effects of long-term antipsychotic treatment on NMDA receptor binding and gene expression of subunits","volume":"28","author":"Schmitt","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000026566","article-title":"Chronic oral haloperidol and clozapine in rats: a behavioral evaluation","volume":"39","author":"Schmitt","year":"1999","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ejphar.2024.176567_bib57","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1080\/14656566.2018.1509069","article-title":"Using antipsychotics for behavioral problems in children","volume":"19","author":"Shafiq","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2024.176567_bib58","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1523\/JNEUROSCI.23-01-00297.2003","article-title":"Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring","volume":"23","author":"Shi","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176567_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0269881113512039","article-title":"Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model","volume":"28","author":"Shu","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib60","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbr.2014.07.042","article-title":"Asenapine sensitization from adolescence to adulthood and its potential molecular basis","volume":"273","author":"Shu","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib61","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/13154","article-title":"In vivo evidence for post-adolescent brain maturation in frontal and striatal regions","volume":"2","author":"Sowell","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176567_bib62","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejphar.2008.11.036","article-title":"Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs","volume":"602","author":"Sun","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2010.02.024","article-title":"Iptakalim: a potential antipsychotic drug with novel mechanisms?","volume":"634","author":"Sun","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/FBP.0b013e32835651ea","article-title":"Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval","volume":"23","author":"Swalve","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib65","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1176\/ajp.152.5.698","article-title":"Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients","volume":"152","author":"Szymanski","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib66","first-page":"711","article-title":"Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment","volume":"297","author":"Tarazi","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2024.176567_bib67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-3806(95)00109-Q","article-title":"Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens","volume":"89","author":"Teicher","year":"1995","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib68","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1017\/S1461145712001642","article-title":"Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function","volume":"16","author":"Vinish","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib69","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamapsychiatry.2020.0036","article-title":"Effects of antipsychotic medication on brain structure in patients with major depressive disorder and psychotic features: neuroimaging findings in the context of a randomized placebo-controlled clinical trial","volume":"77","author":"Voineskos","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib70","doi-asserted-by":"crossref","first-page":"168","DOI":"10.9758\/cpn.2012.10.3.168","article-title":"Iptakalim preferentially decreases nicotine-induced hyperlocomotion in phencyclidine-sensitized rats: a potential dual action against nicotine addiction and psychosis","volume":"10","author":"Volf","year":"2012","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176567_bib71","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1523\/JNEUROSCI.4831-11.2012","article-title":"Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments","volume":"32","author":"Vuillermot","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176567_bib72","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-7634(99)00037-8","article-title":"The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?","volume":"23","author":"Wadenberg","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2024.176567_bib73","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.bbr.2008.02.021","article-title":"Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring","volume":"190","author":"Wolff","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib74","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbr.2010.05.008","article-title":"The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss","volume":"213","author":"Wolff","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib75","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jpsychires.2012.05.010","article-title":"Increased affective ultrasonic communication during fear learning in adult male rats exposed to maternal immune activation","volume":"46","author":"Yee","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pbb.2010.12.018","article-title":"Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence","volume":"98","author":"Zhang","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2024.176567_bib77","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/FBP.0b013e32834ecac4","article-title":"Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine","volume":"23","author":"Zhang","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176567_bib78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbr.2016.04.006","article-title":"Behavioral and pharmacological validation of an integrated fear-potentiated startle and prepulse inhibition paradigm","volume":"307","author":"Zhang","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2024.176567_bib79","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pnpbp.2012.03.007","article-title":"Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion","volume":"38","author":"Zhao","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2024.176567_bib80","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/sj.npp.1300248","article-title":"Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia","volume":"28","author":"Zuckerman","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2024.176567_bib81","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychires.2004.08.008","article-title":"Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring","volume":"39","author":"Zuckerman","year":"2005","journal-title":"J. Psychiatr. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924002553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T17:22:44Z","timestamp":1731691364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924002553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":81,"alternative-id":["S0014299924002553"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176567","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous oral olanzapine or clozapine treatment initiated in adolescence has differential short- and long-term impacts on antipsychotic sensitivity than those initiated in adulthood","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176567"}}